Published in J Biol Chem on July 25, 1975
Regulation of ribosomal RNA promoters with a synthetic lac operator. Proc Natl Acad Sci U S A (1984) 5.92
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol (1977) 2.99
Small stable RNAs from Escherichia coli: evidence for the existence of new molecules and for a new ribonucleoprotein particle containing 6S RNA. J Bacteriol (1978) 2.01
Compilation of small RNA sequences. Nucleic Acids Res (1986) 1.92
Compilation of small RNA sequences. Nucleic Acids Res (1988) 1.53
Low-molecular-weight (4.5S) ribonucleic acid in higher-plant chloroplast ribosomes. Biochem J (1978) 1.45
Loss of 4.5S RNA induces the heat shock response and lambda prophage in Escherichia coli. J Bacteriol (1990) 1.36
Location of a gene (ssrA) for a small, stable RNA (10Sa RNA) in the Escherichia coli chromosome. J Bacteriol (1990) 1.22
Ribonuclease P substrate specificity: cleavage of a bacteriophage phi80-induced RNA. Proc Natl Acad Sci U S A (1976) 1.18
4.5S ribonucleic acid, a novel ribosome component in the chloroplasts of flowering plants. Biochem J (1979) 1.16
Compilation of small RNA sequences. Nucleic Acids Res (1985) 1.08
The sequence of the 6S RNA gene of Pseudomonas aeruginosa. Nucleic Acids Res (1987) 0.91
Physical properties of the E. coli 4.5S RNA: first results suggest a hairpin helix of unusual thermal stability. Nucleic Acids Res (1984) 0.84
Coding potential and regulatory signals of the polyoma virus genome. Nature (1980) 11.24
Polyoma DNA: a physical map. Proc Natl Acad Sci U S A (1974) 7.36
Organization of the genomes of polyoma virus and SV40. Adv Cancer Res (1977) 3.53
Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens. Cell (1979) 3.29
Isolation of human lymphotropic herpesviruses from Uganda. Lancet (1987) 3.26
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res (1981) 2.83
New classes of viable deletion mutants in the early region of polyoma virus. J Virol (1979) 2.75
Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol (1981) 2.43
The synthesis of oligoribonucleotides. IV. Preparation of dinucleoside phosphates from 2',5'-protected ribonucleoside derivatives. Tetrahedron (1968) 2.31
5 s RNA conformation. Studies of its partial T 1 ribonuclease digestion by gel electrophoresis and two-dimensional thin-layer chromatography. J Mol Biol (1972) 2.21
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J (1984) 2.00
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus. J Virol (1980) 1.96
Amplification of a specific region of the polyoma virus genome. Nature (1975) 1.92
Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J Virol (1985) 1.91
Immortalization of monkey epithelial cells by specific fragments of Epstein-Barr virus DNA. Nature (1984) 1.90
Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A (1982) 1.73
Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol (1992) 1.66
Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci U S A (1992) 1.66
Cooperation of structural proteins during late events in the life cycle of polyomavirus. J Virol (1993) 1.58
Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Res (1991) 1.57
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol (2000) 1.57
Oligoribonucleotide synthesis from nucleoside 2'-O-benzyl ethers. Tetrahedron Lett (1966) 1.54
Coding capacity of a 35 percent fragment of the polyoma virus genome is sufficient to initiate and maintain cellular transformation. Proc Natl Acad Sci U S A (1980) 1.53
Clustered repeat sequences in the genome of Epstein Barr virus. Nucleic Acids Res (1983) 1.53
DNA sequences of polyoma virus early deletion mutants. J Virol (1981) 1.51
Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology (1992) 1.47
DNA binding activity of polyoma virus large tumor antigen. Proc Natl Acad Sci U S A (1984) 1.47
Fine structure of polyoma virus DNA. J Mol Biol (1977) 1.45
Sequences from the genome of a non-transforming mutant of polyoma virus. Nature (1978) 1.41
The synthesis of oligoribonucleotides. II. Methoxymethylidene derivatives of ribonucleosides and 5'-ribonucleotides. Tetrahedron (1967) 1.39
Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product? Cold Spring Harb Symp Quant Biol (1980) 1.39
Polyoma virus DNA: complete nucleotide sequence of the gene which codes for polyoma virus capsid protein VP1 and overlaps the VP2/VP3 genes. J Virol (1980) 1.36
EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J (1994) 1.29
Host-dependent evolution of three papova viruses. Nature (1980) 1.28
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
The synthesis of oligoribonucleotides. 3. Monoacylation of ribonucleosides and derivatives via orthoester exchange. Tetrahedron (1967) 1.24
Characterization of the DNA polymerase gene of human herpesvirus 6. J Virol (1991) 1.21
Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol (1993) 1.19
Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res (1988) 1.18
Polyoma virus. The early region and its T-antigens. Nucleic Acids Res (1979) 1.18
Myristylated polyomavirus VP2: role in the life cycle of the virus. J Virol (1990) 1.17
A Preliminary Genetic Investigation of VOLVOX CARTERI. Genetics (1979) 1.17
Polyomavirus: an overview of its unique properties. Adv Cancer Res (1983) 1.16
Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene (1995) 1.14
Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens. Oncogene (1990) 1.14
Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer (2003) 1.11
Requirement for the C-terminal region of middle T-antigen in cellular transformation by polyoma virus. Nucleic Acids Res (1981) 1.10
Polyoma virus DNA: Sequence from the late region that specifies the leader sequence for late mRNA and codes for VP2, VP3, and the N-terminus of VP1. J Virol (1980) 1.10
Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Ther (2000) 1.08
Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum Gene Ther (1995) 1.04
Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol (2003) 1.03
Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol (1998) 1.01
Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location. Proc Natl Acad Sci U S A (1987) 1.01
Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol (1989) 1.01
Precursors of stable RNA accumulated in a mutant of E. coli. FEBS Lett (1973) 0.99
CpG methylation of viral DNA in EBV-associated tumours. Int J Cancer (1990) 0.98
Subcellular localisation of the middle and large T-antigens of polyoma virus. EMBO J (1986) 0.97
Genetic control of somatic cell differentiation in Volvox analysis of somatic regenerator mutants. Dev Biol (1979) 0.96
Variation in restriction map of MHV-6 genome. Lancet (1989) 0.96
Pulse oximetry: what's normal in the newborn nursery? Pediatr Pulmonol (2000) 0.95
Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma? Br J Cancer (1993) 0.94
Efficient oligodeoxyribonucleotide-directed deletion mutagenesis using pEMBL vectors: removal of early region introns from polyoma virus mutants. Gene (1986) 0.94
Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther (1998) 0.94
Orientation of ribonucleoside derivatives by proton magnetic resonance spectroscopy. Tetrahedron (1966) 0.94
Polyoma virus defective DNAs. I. Physical maps of a related set of defective molecules (D76, D91, D92). J Mol Biol (1977) 0.92
Polyoma virus defective DNAs. II. Physical map of a molecule with rearranged and reiterated sequences (D74). J Mol Biol (1977) 0.92
Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int J Cancer (1999) 0.92
Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids. Gene Ther (2000) 0.91
Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA. Int J Cancer (1990) 0.91
Mutant din-21, a variant of polyoma virus containing a mouse DNA sequence in the viral genome. EMBO J (1982) 0.91
Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Lett (1999) 0.91
mlt Mutants of polyoma virus. J Virol (1982) 0.91
Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells. Int J Cancer (1995) 0.91
Visualization of single copies of the Epstein-Barr virus genome by in situ hybridization. Anal Biochem (1990) 0.90
Tissue distribution of Epstein-Barr virus genotypes. J Virol (1996) 0.89
Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi. J Virol (1997) 0.88
Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene (1992) 0.88
Cellular immortalization--an essential step or merely a risk factor in DNA virus-induced transformation? Cancer Cells (1990) 0.87
Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses. Nucleic Acids Res (1989) 0.84
Expression of two related viral early genes in Epstein-Barr virus-associated tumors. J Virol (2000) 0.84
Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen. Exp Cell Res (1991) 0.84
Size heterogeneity of EBV and mitochondrial DNAs in Burkitt's lymphoma lines. Nucleic Acids Res (1987) 0.83
African Burkitt's lymphoma: a new perspective. Trans R Soc Trop Med Hyg (2001) 0.82
The synthesis of oligoribonucleotides. V. The preparation of some dinucleotides and trinucleoside diphosphates. Tetrahedron (1968) 0.82
Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript. Mol Cell Biol (1999) 0.80
The transforming gene of polyoma virus. Arch Geschwulstforsch (1983) 0.80
Immunological variation in the 'common region' of the T antigens of polyoma virus. J Gen Virol (1987) 0.80
Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium. J Oral Pathol Med (1991) 0.80
Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria. Chin Med J (Engl) (1998) 0.80
The methylation of adenylyl-(3'-5')-uridine and uridylyl-(3'-5')-adenosine with diazomethane. Biochim Biophys Acta (1967) 0.79
Regulation of cytoskeletal association by a basic amino acid motif in polyoma virus middle T antigen. Oncogene (1998) 0.79
A paralytic disease in nude mice associated with polyoma virus infection. J Gen Virol (1983) 0.78
Polyoma virus: some considerations on its transforming genes. Proc R Soc Lond B Biol Sci (1980) 0.78
Polyoma and papilloma virus vectors for cancer gene therapy. Adv Exp Med Biol (2000) 0.78
Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge. J Med Virol (1998) 0.78